Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health Outcomes

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Massachusetts, Worcester

About this trial

This project tests a training strategy to help rural jails start or increase their use of medications to treat opioid use disorder (MOUD - methadone, buprenorphine, naltrexone). Staff from participating jails will attend a series of training sessions, called Project ECHO, that include online learning sessions with skilled experts, case-based discussions (real-world examples), and peer-to-peer learning opportunities. Project ECHO is well-studied in healthcare settings but has rarely been used in correctional systems. Staff from 40 rural jails and local treatment programs will participate in 6 months of core sessions (all participants attend the same sessions), followed by 12 months of continuing sessions (where content is tailored to participants' needs). Staff will complete surveys about their knowledge and experience, and jails will provide data about their services. Researchers will measure changes in MOUD services offered by the jails over time, as well as the impact these changes have on staff's work environment. If Project ECHO helps expand MOUD services, it will offer a blueprint for expanding these life-saving services in other jails nationwide.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Administrative, security, or healthcare staff in participating jails

Employed at the facility a minimum of 3 months

Disqualifiers

Ongoing or recent participation in similar organizational improvement project

Inability to read or understand English or Spanish

Trial design

Design model

Single group

Treatments tested in this trial

  • Project ECHO

    Behavioral

    Virtual learning sessions, case-based discussions, and peer-to-peer learning

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: ECHOExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Increase in MOUD prescriptions (administrative data)

Administrative data tracking the number of MOUD prescriptions will be used to assess whether the jail has increased its use of MOUD to treat opioid use disorder relative to baseline.

Time frame
From baseline through the end of sustainment phase (18 months)

Secondary outcomes

1

Organizational climate - Burnout (BAT-4)

Staff surveys measure Burnout via the 4-item Burnout Assessment Tool (BAT-4). Items are scored from 1 (never) to 5 (always), and the mean is calculated (higher scores = greater burnout). Change relative to baseline indicates impact of the intervention on this feature of organizational climate.

Time frame
From baseline to end of sustainment period (18 months)
2

Organizational climate - Stress (TCU SOF subscale)

Staff surveys measure Stress via a validated 4-item subscale of the TCU Survey of Organizational Functioning. Items are scored from 1 (disagree) to 5 (agree), and the mean is calculated (higher scores = greater perceived stress). Change relative to baseline indicates impact of the intervention on this feature of organizational climate.

Time frame
From baseline through end of sustainment period (18 months)
3

Organizational climate - Job Satisfaction (TCU SOF subscale)

Staff surveys measure job satisfaction using a 6-item validated subscale from the TCU Survey of Organizational Functioning. Items are scored from 1 (strongly disagree) to 5 (strongly agree), and the mean is calculated (higher scores = greater job satisfaction). Change relative to baseline indicates impact of the intervention on this feature of organizational climate.

Time frame
From baseline through end of sustainment period (18 months)
4

Impact on Staff Knowledge: Opinions About MAT Questionnaire

Staff surveys include this 12-item scale, measuring familiarity, receipt of training, and perceived effectiveness of 4 formulations of medications for opioid use disorder. Each item is rated on a 1-5 scale, with higher scores reflecting stronger endorsement. Overall improvements in any of the 3 domains relative to baseline will indicate the intervention had a positive impact on staff knowledge about MOUD.

Time frame
From baseline through end of sustainment period (18 months)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Massachusetts, Worcester

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: